192 related articles for article (PubMed ID: 31079233)
21. [Endometrial metaplasia].
Zhang XM; Dong Y; Li T
Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):561-5. PubMed ID: 24246928
[No Abstract] [Full Text] [Related]
22. Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia.
Sun H; Enomoto T; Fujita M; Wada H; Yoshino K; Ozaki K; Nakamura T; Murata Y
Am J Clin Pathol; 2001 Jan; 115(1):32-8. PubMed ID: 11190805
[TBL] [Abstract][Full Text] [Related]
23. Endometrial metaplasia associated with endometrial carcinoma.
Kaku T; Tsukamoto N; Tsuruchi N; Sugihara K; Kamura T; Nakano H
Obstet Gynecol; 1992 Nov; 80(5):812-6. PubMed ID: 1407921
[TBL] [Abstract][Full Text] [Related]
24. PINCH protein expression in normal endometrium, atypical endometrial hyperplasia and endometrioid endometrial carcinoma.
Zhang HZ; Li XH; Zhang X; Zhang ZY; Meng YL; Xu SW; Zheng Y; Zhu ZL; Cui DS; Huang LX; Yan BY; Sun XF
Chemotherapy; 2010; 56(4):291-7. PubMed ID: 20714146
[TBL] [Abstract][Full Text] [Related]
25. Frequent KRAS mutation in complex mucinous epithelial lesions of the endometrium.
Alomari A; Abi-Raad R; Buza N; Hui P
Mod Pathol; 2014 May; 27(5):675-80. PubMed ID: 24186144
[TBL] [Abstract][Full Text] [Related]
26. Endometrial carcinoma associated with hyperplasia.
Kaku T; Tsukamoto N; Hachisuga T; Tsuruchi N; Sakai K; Hirakawa T; Amada S; Saito T; Kamura T; Nakano H
Gynecol Oncol; 1996 Jan; 60(1):22-5. PubMed ID: 8557221
[TBL] [Abstract][Full Text] [Related]
27. Detection of PTEN immunoreactivity in endometrial hyperplasia and adenocarcinoma.
Tantbirojn P; Triratanachat S; Trivijitsilp P; Niruthisard S
J Med Assoc Thai; 2008 Aug; 91(8):1161-5. PubMed ID: 18788685
[TBL] [Abstract][Full Text] [Related]
28. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
[TBL] [Abstract][Full Text] [Related]
29. Complex papillary hyperplasia of the endometrium: an uncommon case report with cytopathological features and diagnostic implications.
Rekhi B; Menon S; Maheshwari A
Diagn Cytopathol; 2015 Feb; 43(2):163-8. PubMed ID: 24825243
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic mutations in histologically normal endometrium: the new normal?
Lac V; Nazeran TM; Tessier-Cloutier B; Aguirre-Hernandez R; Albert A; Lum A; Khattra J; Praetorius T; Mason M; Chiu D; Köbel M; Yong PJ; Gilks BC; Anglesio MS; Huntsman DG
J Pathol; 2019 Oct; 249(2):173-181. PubMed ID: 31187483
[TBL] [Abstract][Full Text] [Related]
31. Endometrial intraepithelial neoplasia.
Owings RA; Quick CM
Arch Pathol Lab Med; 2014 Apr; 138(4):484-91. PubMed ID: 24678678
[TBL] [Abstract][Full Text] [Related]
32. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
[TBL] [Abstract][Full Text] [Related]
33. Mucinous metaplasia of the endometrium: current concepts.
Turashvili G; Childs T
Gynecol Oncol; 2015 Feb; 136(2):389-93. PubMed ID: 25485781
[TBL] [Abstract][Full Text] [Related]
34. [Endometrial atypical complex hyperplasia with extensive squamous metaplasia: two cases].
Hannachi Sassi S; Dhouib R; Abbes I; Braham E; Mrad K; Driss M; Ben Hamida N; Ben Romdhane K
Ann Pathol; 2008 Jun; 28(3):233-6. PubMed ID: 18706369
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of endometrium associated with papillary metaplastic changes in endometrial cytopathology.
Shimizu K; Norimatsu Y; Kobayashi TK; Sakurai M; Ogura S; Yoshizawa A; Sakurai T; Miyamoto T; Miyake Y; Aratake Y; Sakaguchi T; Ohno E
Diagn Cytopathol; 2009 Jul; 37(7):487-91. PubMed ID: 19263487
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic application of KRAS mutation testing in uterine microglandular proliferations.
Hong W; Abi-Raad R; Alomari AK; Hui P; Buza N
Hum Pathol; 2015 Jul; 46(7):1000-5. PubMed ID: 25997988
[TBL] [Abstract][Full Text] [Related]
37. PROLIFERATIVE/STEM CELL INDEX AND PHENOTYPIC CHARACTERISTICS OF PROLIFERATIVE PROCESSES IN ENDOMETRIUM.
Kikalishvili N; Beriashvili R; Muzashvili T; Burkadze G
Georgian Med News; 2018 Sep; (282):156-161. PubMed ID: 30358561
[TBL] [Abstract][Full Text] [Related]
38. Expression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma.
Lee H; Choi HJ; Kang CS; Lee HJ; Lee WS; Park CS
Mod Pathol; 2012 Nov; 25(11):1508-15. PubMed ID: 22766795
[TBL] [Abstract][Full Text] [Related]
39. Co-existing TP53 and ARID1A mutations promote aggressive endometrial tumorigenesis.
Reske JJ; Wilson MR; Holladay J; Siwicki RA; Skalski H; Harkins S; Adams M; Risinger JI; Hostetter G; Lin K; Chandler RL
PLoS Genet; 2021 Dec; 17(12):e1009986. PubMed ID: 34941867
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
